NCT00605618View on ClinicalTrials.gov

Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Advanced Solid Tumors
Interventions
DRUG

BMS-777607

Suspension/Tablet, Oral, Dose escalation to an MTD from a starting dose of 10 mg, once daily, until disease progression/subject discontinuation

Trial Locations (2)

2050

Local Institution, Camperdown

2217

Local Institution, Kogarah

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00605618 - Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter